← FDA DRUG APPROVALS

FDA ANDA · ANDA075773

PAMIDRONATE DISODIUM

Sponsor: FRESENIUS KABI USA

APPLICATION
ANDA075773
TYPE
ANDA
ORIGINAL APPROVAL
2002-05-06
LATEST ACTION
2002-12-05
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

PAMIDRONATE DISODIUMDiscontinued
PAMIDRONATE DISODIUM 90MG/VIAL · INJECTABLE · INJECTION
PAMIDRONATE DISODIUMDiscontinued
PAMIDRONATE DISODIUM 30MG/VIAL · INJECTABLE · INJECTION

Approval history

2002-12-05Manufacturing (CMC) · Supplement 1 — Other Important Information from FDA ↗AP
2002-05-06Original — Other Important Information from FDA ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →